JNJ
JOHNSON & JOHNSONC5015-min delayed · EOD close266.34 +0.29% upas of 2026-09-14mkt cap $641B
Pharmaceutical Preparations · SIC 2834 · CIK 0000200406
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $99.3B | 2026-09-27 | 10-Q · 0000200406-26-000197 |
| Revenue (prior year) | $88.8B | 2024-12-29 | 10-K · 0000200406-25-000038 |
| Gross profit | $67.1B | 2026-09-27 | 10-Q · 0000200406-26-000197 |
| Operating income | $21.8B | 2015-03-29 | 10-Q · 0000200406-15-000019 |
| Net income | $16.1B | 2026-09-27 | 10-Q · 0000200406-26-000197 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $197B | 2026-09-27 | 10-Q · 0000200406-26-000197 |
| Current assets | $56.4B | 2026-09-27 | 10-Q · 0000200406-26-000197 |